Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power

The New York Times reported:

 

When 12,000 public health professionals gathered in Minneapolis last week for the annual meeting of the American Public Health Association, Dr. Jerome Adams, who served as surgeon general in the first administration of President-elect Donald J. Trump, issued a pointed warning about Robert F. Kennedy Jr.

“If R.F.K. has a significant influence on the next administration, that could further erode people’s willingness to get up to date with recommended vaccines,” Dr. Adams said. “I am worried about the impact that could have on our nation’s health, on our nation’s economy, on our global security.”